Literature DB >> 28426361

Sociodemographic and Substance Use Disorder Determinants of HIV Sexual Risk Behavior in Men and Women in Outpatient Drug Treatment in the NIDA National Drug Abuse Treatment Clinical Trials Network.

Jeremy D Kidd1,2, Susan Tross1,2, Martina Pavlicova3, Mei-Chen Hu2, Aimee N C Campbell1,2, Edward V Nunes1,2.   

Abstract

BACKGROUND: Sexual risk behavior is now the primary vector of HIV transmission among substance users in the United States with gender as a crucial moderator of risk behavior.
OBJECTIVES: The purpose of this study was to examine gender differences in factors (age, race/ethnicity, education) that predict main-partner unprotected sexual occasions (USO) using the unique platform of two parallel NIDA National Drug Abuse Treatment Clinical Trials Network gender-specific safer sex intervention trials.
METHODS: Baseline assessments of male (N = 430) and female (N = 377) participants included demographic characteristics; past 3-month sexual activity; and a diagnostic assessment for alcohol, cocaine/stimulant, and opioid use disorders. Using mixed effects generalized linear modeling of the main outcome USO, two-way interactions of gender with age, race/ethnicity, and education were evaluated and adjusted by alcohol, cocaine/stimulant, or opioid use disorder.
RESULTS: When adjusted for alcohol use disorder, the interaction of education and gender was significant. For men, a high school or greater education was significantly associated with more USO compared to men with less than high school. For women, greater than high school education was significantly associated with less USO compared to women with a high school education. None of the other interactions were significant when adjusted for cocaine/stimulant or opioid use disorder. Conclusions/Importance: This study demonstrates gender differences in the relationship of education, alcohol use disorder, and main-partner USO in individuals in substance abuse treatment. This underscores the importance of considering demographic and substance use factors in HIV sexual risk behavior and in crafting prevention messages for this population.

Entities:  

Keywords:  HIV; gender; sexual risk; substance abuse treatment

Mesh:

Year:  2017        PMID: 28426361      PMCID: PMC5710008          DOI: 10.1080/10826084.2016.1264971

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  42 in total

1.  HIV in adolescents and young adults: half of all new infections in the United States.

Authors:  Donna C Futterman
Journal:  Top HIV Med       Date:  2005 Aug-Sep

2.  Non-injection and injection drug use and STI/HIV risk in the United States: the degree to which sexual risk behaviors versus sex with an STI-infected partner account for infection transmission among drug users.

Authors:  Maria R Khan; Amanda Berger; Jordana Hemberg; Allison O'Neill; Typhanye Penniman Dyer; Kristina Smyrk
Journal:  AIDS Behav       Date:  2013-03

3.  The care of persons with recent sexual exposure to HIV.

Authors:  M H Katz; J L Gerberding
Journal:  Ann Intern Med       Date:  1998-02-15       Impact factor: 25.391

4.  Association of methamphetamine use during sex with risky sexual behaviors and HIV infection among non-injection drug users.

Authors:  F Molitor; S R Truax; J D Ruiz; R K Sun
Journal:  West J Med       Date:  1998-02

5.  Twenty-five years of HIV/AIDS--United States, 1981-2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-06-02       Impact factor: 17.586

6.  The Impact of Condom Use Negotiation Self-Efficacy and Partnership Patterns on Consistent Condom Use Among College-Educated Women.

Authors:  Elizabeth D Nesoff; Kristin Dunkle; Delia Lang
Journal:  Health Educ Behav       Date:  2015-07-20

Review 7.  Alcohol as a correlate of unprotected sexual behavior among people living with HIV/AIDS: review and meta-analysis.

Authors:  Paul A Shuper; Narges Joharchi; Hyacinth Irving; Jürgen Rehm
Journal:  AIDS Behav       Date:  2009-07-18

Review 8.  HIV sex risk behaviors among heterosexual methamphetamine users: literature review from 2000 to present.

Authors:  Karen F Corsi; Robert E Booth
Journal:  Curr Drug Abuse Rev       Date:  2008-11

9.  Predictors of risky sexual behavior with new and regular partners in a sample of women bar drinkers.

Authors:  Kathleen A Parks; Ya-Ping Hsieh; R Lorraine Collins; Kristina Levonyan-Radloff; Linda P King
Journal:  J Stud Alcohol Drugs       Date:  2009-03       Impact factor: 2.582

10.  The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3).

Authors:  Kaye Wellings; Kyle G Jones; Catherine H Mercer; Clare Tanton; Soazig Clifton; Jessica Datta; Andrew J Copas; Bob Erens; Lorna J Gibson; Wendy Macdowall; Pam Sonnenberg; Andrew Phelps; Anne M Johnson
Journal:  Lancet       Date:  2013-11-26       Impact factor: 79.321

View more
  3 in total

1.  Drug use by men admitted to a psychiatric hospital.

Authors:  Aroldo Gavioli; Patrícia Tieme Nishimura Pazin; Sonia Regina Marangoni; Anai Adario Hungaro; Cleiton José Santana; Magda Lúcia Felix de Oliveira
Journal:  Rev Lat Am Enfermagem       Date:  2020-06-19

2.  Donor-derived human herpesvirus 8 and development of Kaposi sarcoma among 6 recipients of organs from donors with high-risk sexual and substance use behavior.

Authors:  Sheila C Dollard; Pallavi Annambhotla; Phili Wong; Katherine Meneses; Minal M Amin; Ricardo M La Hoz; Erika D Lease; Maria Budev; Andrea Valeria Arrossi; Sridhar V Basavaraju; Christie P Thomas
Journal:  Am J Transplant       Date:  2020-08-04       Impact factor: 8.086

3.  Implementation and Evaluation of a Text Message-Based Addiction Counseling Program (Text4Hope-Addiction Support): Protocol for a Questionnaire Study.

Authors:  Vincent Israel Opoku Agyapong; Marianne Hrabok; Wesley Vuong; April Gusnowski; Reham Shalaby; Shireen Surood; Andrew J Greenshaw; Avininder Aulakh; Adam Abba-Aji; Mohit Singh
Journal:  JMIR Res Protoc       Date:  2020-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.